Straits Times Index
3,300.04 -3.15 (-0.10%) S&P 500
5,195.60 +14.86 (+0.29%) Dow
38,956.84 +104.57 (+0.27%) Nasdaq
16,381.80 +32.56 (+0.20%) Bitcoin USD
63,934.45 +837.41 (+1.33%) CMC Crypto 200
1,322.17 -42.95 (-3.15%)
Ironwood Pharmaceuticals, Inc. (IRWD)
- Business Wire
Ironwood Pharmaceuticals to Participate in The Citizens JMP Life Sciences Conference
BOSTON, May 06, 2024--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) today announced that management will participate in a fireside chat at The Citizens JMP Life Sciences Conference on Monday, May 13, 2024 at 10:00 a.m. ET at the New York Hilton Midtown.
- Zacks
Earnings Preview: Ironwood Pharmaceuticals (IRWD) Q1 Earnings Expected to Decline
Ironwood (IRWD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Business Wire
Ironwood Pharmaceuticals to Present New Data on Once-Weekly Apraglutide in Short Bowel Syndrome with Intestinal Failure (SBS-IF) at Digestive Disease Week® 2024
BOSTON, May 01, 2024--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, announced today that the company will present new data from studies evaluating apraglutide in adults with short bowel syndrome with intestinal failure (SBS-IF), a condition in which patients are dependent on parenteral support (PS), during the 2024 Digestive Disease Week® (DDW) meeting. DDW is held from May 18-21, 2024, in Washington, D.C.
